Prostate Cancer Clinical Trial
Official title:
Effect of Deep Neuromuscular Block and Variations in Arterial PCO2 on the Surgical Rating Scale (SRS), Extubation Conditions and Postoperative Conditions Following Reversal With Sugammadex
The purpose of this study is to study the effect of variations in the arterial CO2 concentration during deep neuromuscular block on the surgical conditions as assessed by the surgical rating scale
Surgical conditions in laparoscopic surgery are largely determined by the depth of
neuromuscular relaxation during surgery. This is especially true in procedures which are
confined to a narrow working field such as retroperitoneal laparoscopic surgery (eg. renal
and prostatic surgery). In the previous study (BLISS study) deep neuromuscular block (NMB)
has shown to provide superior surgical conditions compared to moderate NMB. Moreover, rapid
reversal of a deep NMB at the end of surgery was possible with Sugammadex (4mg/kg). The deep
NMB did not lead to any delay in extubation time and did not cause any prolongation of stay
in the recovery room when the block was reversed with Sugammadex
Rapid, safe and complete reversal of profound NMB blockade was not possible until the
discovery of Sugammadex. Sugammadex is a modified γ-cyclodextrin. It was developed to
selectively bind free plasma rocuronium, a non-depolarizing steroidal neuromuscular blocking
agent. The BLISS study was the first study in which the effect of deep NMB on surgical
conditions was assessed. Surgical conditions in this study were scored by one surgeon on a
newly applied surgical rating scale which ranges from one to five.
Although the BLISS study showed that a deep NMB provided better surgical conditions than a
moderately deep NMB overall, there was a high variability in surgical rating scores. More
over, even at the deep NMB, SRS scores of 3 (moderate, but acceptable conditions) were noted.
This indicates that surgical conditions are influenced by other factors as well. Involuntary
movement of the diaphragm is possibly such a major disturbant of the surgical field. Previous
studies have shown a relative resistance to neuromuscular blocking agents of the diaphragm
compared to the musclus adductor pollicis on which neuromuscular block is generally
monitored. Hence contractions of the diaphragm may occure despite a deep NMB. This may be due
to (high) arterial carbon dioxide (CO2) concentrations, which stimulate the respiratory
neuronal pool in the brainstem and consequently activate the phrenic nerve. In normal
circumstances, the respiratory centers try to maintain an arterial CO2 pressure of 40 mmHg.
With intentional hyperventilation, the arterial CO2 pressure may be lowered to 10-20 mmHg. A
low arterial CO2 pressure diminishes the respiratory drive and consequently phrenic nerve
activity. This is supported by previous observations which showed increased abdominal muscle
relaxation produced by hyperventilation. We therefore designed this study to evaluate the
effect of arterial CO2 variation with concurrent deep NMB on the surgical conditions.
Arterial CO2 tensions may be altered by adjusting the ventilator settings. Eg. by increasing
minute ventilation volume, arterial CO2 concentration will lower. Regular arterial blood
samples will be drawn to monitor arterial CO2 concentration.
We hypothesize that a Deep NMB combined with hypocapnia will result in a significant
improvement of surgical conditions as rated on the surgical rating scale by one surgeon
compared to deep NMB and normocapnia
Additional secondary end-points of the study include the effect of arterial CO2 variation on:
- economic parameters (time to spontaneous breathing, time to extubation, duration of
surgery, and time in the post-anesthesia care unit)
- perioperative hemodynamics, abdominal pressure
- postoperative conditions (respiratory conditions, hemodynamics, arterial oxygen
saturation, pain, sedation, nausea and vomiting)
- To assess the ability of anesthesiologists and surgeons to rate the surgical field using
video snippets of the surgical field.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT05540392 -
An Acupuncture Study for Prostate Cancer Survivors With Urinary Issues
|
Phase 1/Phase 2 | |
Recruiting |
NCT05613023 -
A Trial of 5 Fraction Prostate SBRT Versus 5 Fraction Prostate and Pelvic Nodal SBRT
|
Phase 3 | |
Recruiting |
NCT05156424 -
A Comparison of Aerobic and Resistance Exercise to Counteract Treatment Side Effects in Men With Prostate Cancer
|
Phase 1/Phase 2 | |
Completed |
NCT03177759 -
Living With Prostate Cancer (LPC)
|
||
Completed |
NCT01331083 -
A Phase II Study of PX-866 in Patients With Recurrent or Metastatic Castration Resistant Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05540782 -
A Study of Cognitive Health in Survivors of Prostate Cancer
|
||
Active, not recruiting |
NCT04742361 -
Efficacy of [18F]PSMA-1007 PET/CT in Patients With Biochemial Recurrent Prostate Cancer
|
Phase 3 | |
Completed |
NCT04400656 -
PROState Pathway Embedded Comparative Trial
|
||
Completed |
NCT02282644 -
Individual Phenotype Analysis in Patients With Castration-Resistant Prostate Cancer With CellSearch® and Flow Cytometry
|
N/A | |
Recruiting |
NCT06037954 -
A Study of Mental Health Care in People With Cancer
|
N/A | |
Recruiting |
NCT06305832 -
Salvage Radiotherapy Combined With Androgen Deprivation Therapy (ADT) With or Without Rezvilutamide in the Treatment of Biochemical Recurrence After Radical Prostatectomy for Prostate Cancer
|
Phase 2 | |
Recruiting |
NCT05761093 -
Patient and Physician Benefit/ Risk Preferences for Treatment of mPC in Hong Kong: a Discrete Choice Experiment
|
||
Completed |
NCT04838626 -
Study of Diagnostic Performance of [18F]CTT1057 for PSMA-positive Tumors Detection
|
Phase 2/Phase 3 | |
Recruiting |
NCT03101176 -
Multiparametric Ultrasound Imaging in Prostate Cancer
|
N/A | |
Completed |
NCT03290417 -
Correlative Analysis of the Genomics of Vitamin D and Omega-3 Fatty Acid Intake in Prostate Cancer
|
N/A | |
Completed |
NCT00341939 -
Retrospective Analysis of a Drug-Metabolizing Genotype in Cancer Patients and Correlation With Pharmacokinetic and Pharmacodynamics Data
|
||
Completed |
NCT01497925 -
Ph 1 Trial of ADI-PEG 20 Plus Docetaxel in Solid Tumors With Emphasis on Prostate Cancer and Non-Small Cell Lung Cancer
|
Phase 1 | |
Recruiting |
NCT03679819 -
Single-center Trial for the Validation of High-resolution Transrectal Ultrasound (Exact Imaging Scanner ExactVu) for the Detection of Prostate Cancer
|
||
Completed |
NCT03554317 -
COMbination of Bipolar Androgen Therapy and Nivolumab
|
Phase 2 | |
Completed |
NCT03271502 -
Effect of Anesthesia on Optic Nerve Sheath Diameter in Patients Undergoing Robot-assisted Laparoscopic Prostatectomy
|
N/A |